BANGKOK, Feb. 10 (Xinhua) -- Thailand's Food and Drug Administration (FDA) said Wednesday that U.S. company Johnson & Johnson is seeking to register its COVID-19 vaccine for emergency use in Thailand.
The FDA said there are three companies that have requested the vaccine emergency use authorization in the Southeast Asian country, with the other two being AstraZeneca and China's Sinovac Biotech.
The FDA said the emergency use authorization in Thailand has a period of one year, and the side effects after use must be followed up to evaluate the vaccine's safety.
On Tuesday, Thai Prime Minister Prayut Chan-o-cha reaffirmed that Thailand's COVID-19 vaccination plan will proceed as planned.
A batch of the Sinovac vaccine are due for delivery to Thailand between February and April, according to Thai Deputy Prime Minister and Public Health Minister Anutin Charnvirakul.